Showing results (351-360 of 372) with videos related to
Sort By:
Pageof 38
European Heart Journal|August 30, 2025
Heart Failure Therapy in Patients with Advanced Cancer Receiving Specialized Palliative Care (EMPATICC trial)Markus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.ESC Heart Failure|October 10, 2018
Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantationMarkus Zabel, Christian Sticherling, Rik Willems, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 3, 2017
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of responseJan-Patrick Stellmann, Markus Krumbholz, Tim Friede, et al.European Heart Journal|June 3, 2021
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF studyEwa A Jankowska, Bridget-Anne Kirwan, Mikhail Kosiborod, et al.European Heart Journal|June 5, 2020
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Stefan D Anker, Javed Butler, Muhammad Shahzeb Khan, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport SyndromeOliver Gross, Clifford E Kashtan, Michelle N Rheault, et al.BMJ (Clinical Research Ed.)|May 11, 2022
Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project)Roberto Bernabei, Francesco Landi, Riccardo Calvani, et al.Lancet (London, England)|November 16, 2020
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trialPiotr Ponikowski, Bridget-Anne Kirwan, Stefan D Anker, et al.European Journal of Heart Failure|April 29, 2025
Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trialsStefan D Anker, Tim Friede, Javed Butler, et al.JACC. Basic to Translational Science|March 25, 2025
Impact of MEK Inhibition on Childhood RASopathy-Associated Hypertrophic CardiomyopathyCordula M Wolf, Martin Zenker, Olga Boleti, et al.Pageof 38